{
  "content": "Google Scholar\n2.\nKotecha D., Holmes J., Krum H. et al: Efficacy of beta-blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 2014; 384: 2235.\nCrossref\nPubMed\nGoogle Scholar\n3.\nCadrin-Tourigny J., Shohoudi A., Roy D. et al: Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. J Am Coll Cardiol HF 2017; 5: 99.\nGoogle Scholar\n4.\nJulian D.G., Camm A.J., Frangin G. et al: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction. Lancet 1997; 349: 667.\nCrossref\nPubMed\nGoogle Scholar\n5.",
  "source": "https://www.jacc.org/doi/10.1016/j.jchf.2017.02.003",
  "chunk_id": "8a37db4d-ffdd-4537-8062-75ff1ee882c8",
  "similarity_score": 0.31459587812423706,
  "query": "atrial fibrillation mortality outcomes cardiovascular events stroke prevention amiodarone beta-blockers hazard ratio",
  "rank": 32,
  "title": "Amiodarone and Beta-Blockers in Patients With Heart Failure and Atrial Fibrillation",
  "authors": "Julia Cadrin-Tourigny, Azadeh Shohoudi, Denis Roy, Paul Khairy",
  "year": "2017",
  "journal": "JACC: Heart Failure",
  "reference": "Cadrin-Tourigny, J., Shohoudi, A., Roy, D., & Khairy, P. (2017). Amiodarone and beta-blockers in patients with heart failure and atrial fibrillation. JACC: Heart Failure, 5(4), 312-313.",
  "doi": "Not available",
  "chunk_index": 9,
  "total_chunks": 16,
  "retrieved_at": "2025-07-24T21:57:59.084682"
}